NasdaqHealth CareHealth Care ServicesS&P SmallCap 600
$124.31
-2.50 (-1.97%)
Close of Nov 06, 2026 · end-of-day data
ADUS 8-K filings in 2024
Every material Form 8-K Addus HomeCare filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Addus HomeCare Corporation said its subsidiary completed the purchase of the personal care business of Curo Health Services, which does business as Gentiva, on December 2, 2024. The cash price was $350 million, subject to customary adjustments, and the deal adds operations in seven states, including Texas and Missouri, where the company says it will become the largest personal care provider in Texas. The filing does not include financial results for the acquired business, and the company's financial statements for the deal will be filed by amendment.
Purchase price: $350 million in cash, subject to customary working capital and other adjustments
Company states the acquired business adds annualized revenues of approximately $280 million
Funded through the existing revolving credit facility and part of the proceeds of a June 28, 2024 public offering of common stock
Operations in Arizona, Arkansas, California, Missouri, North Carolina, Tennessee and Texas; acquired financial statements and pro forma information to follow by amendment
Addus HomeCare reported third-quarter 2024 results on November 4, 2024, with net service revenues up 7.0% to $289.8 million and net income up to $20.2 million, or $1.10 per diluted share, from $15.4 million, or $0.95, a year earlier. The company said the Gentiva personal care acquisition is expected to close in the fourth quarter of 2024, and the release did not include updated full-year guidance.
Net service revenues rose 7.0% to $289.8 million, compared with $270.7 million in the third quarter of 2023.
Net income was $20.2 million, or $1.10 per diluted share, versus $15.4 million, or $0.95, a year earlier.
Adjusted net income per diluted share rose 13.0% to $1.30; Adjusted EBITDA rose 11.1% to $34.3 million.
Addus expects to close the Gentiva personal care acquisition in the fourth quarter of 2024.
Addus HomeCare Corporation entered into a Fourth Amendment to its credit agreement on October 22, 2024, with Capital One, National Association, as administrative agent. The amendment increases the revolving credit facility to $650 million and the incremental loan facility to $150 million, and extends the facility's maturity from July 30, 2026 to July 30, 2028. For shareholders, the filing shows expanded borrowing capacity and a longer debt maturity runway, but it does not state how much has been drawn.
Revolving credit facility increased to an aggregate $650 million
Incremental loan facility increased to an aggregate $150 million
Maturity extended from July 30, 2026 to July 30, 2028
Amendment dated October 22, 2024; the 8-K was filed October 23, 2024
Addus HomeCare reported second-quarter 2024 net service revenues of $286.9 million, up 10.4% from a year earlier, with net income of $18.1 million, or $1.10 per diluted share, compared with $14.9 million, or $0.91, in the prior-year quarter. Results also covered a pending $350.0 million acquisition of Gentiva's personal care operations, a planned sale of its New York operations, and a public offering that raised net proceeds of about $176.1 million.
Net service revenues rose 10.4% to $286.9 million; adjusted EBITDA rose 24.7% to $35.3 million.
Net income was $18.1 million, or $1.10 per diluted share, versus $0.91 a year earlier; adjusted EPS was $1.35 versus $1.07.
Cash was $173.3 million at June 30, 2024; about $81.4 million of offering proceeds repaid all credit facility debt.
The Gentiva acquisition is expected to close in the fourth quarter of 2024, subject to regulatory approvals.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Addus HomeCare filing is on SEC EDGAR ↗. 8-K briefs of other companies →